Designed for qualitative detection of COVID-19 IgG and IgM antibodies in serum, plasma, venous whole blood, and fingerstick whole blood samples.
Eligible for use in laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, capable of conducting high, moderate, or waived complexity tests.
CLIA Waived for fingerstick whole blood specimens, offering flexibility for testing in various healthcare settings.
Includes 20 tests per kit, ensuring ample supply for clinical or laboratory use.
Manufactured by Premier Biotech, ensuring quality and reliability in diagnostic testing.
